Senior Director, Pharmacy Clinical Quality & Therapeutic Optimization - Dallas, Tx

Texas Oncology is looking for a Senior Director, Pharmacy Clinical Quality & Therapeutic Optimization to join our team! This role owns the clinical quality vision and execution across oncology pharmacy programs, ensuring alignment between standards of care, payer requirements, manufacturer strategies, pathway governance, and contract performance.

Texas Oncology is the largest community oncology provider in the country and has approximately 600+ providers in 300+ sites across Texas and southeastern Oklahoma. Our founders pioneered community-based cancer care because they believed in making the best available cancer care accessible to all communities, allowing people to fight cancer at home with the critical support of family and friends nearby. Our mission is still the same today-at Texas Oncology, we use leading-edge technology and research to deliver high-quality, high-touch, evidence-based cancer care to help our patients achieve "More breakthroughs. More victories." in their fight against cancer. Today, Texas Oncology treats half of all Texans diagnosed with cancer on an annual basis.

Why work for us?

Come join our team that is responsible for helping lead Texas Oncology in treating more patient diagnosed with cancer than any other provider in Texas. We offer our employees a competitive benefits package that includes Medical, Dental, Vision, Life Insurance, Short-term and Long-term disability coverage, a generous PTO program, a 401k plan that comes with a company match, a Wellness program that rewards you practicing a healthy lifestyle, and lots of other great perks such as Tuition Reimbursement, an Employee Assistance program and discounts on some of your favorite retailers.

Join a Team That Invests in Your Future

At Texas Oncology, we recognize the long-term impact of our people and are committed to rewarding performance and potential. That's why select roles may be eligible to participate in our Long-Term Incentive Plan (LTIP): an incentive program designed to attract, retain, and reward top talent.

What is the Long-Term Incentive Plan (LTIP)?

Long-Term Incentive Plan (LTIP): is an incentive program that typically vests over a three-year period and is tied to both individual performance and the operational success of Texas Oncology. Awards are discretionary and based on your position, performance, and potential for future career growth at Texas Oncology. Awards are reviewed and approved during the annual compensation review. LTIP awards are subject to your continued employment through the award payment date, and are governed by the written terms and conditions of the LTIP document.

What does the Senior Director, Pharmacy Clinical Quality & Therapeutic Optimization do? (including but not limited to) The Senior Director, Pharmacy Clinical Quality & Therapeutic Optimization provides enterprise leadership for oncology pharmacy clinical quality, therapeutic optimization, and value based strategy. The Senior Director serves as the organization's senior clinical authority for oncology pharmacy optimization, responsible for driving measurable outcomes in therapeutic interchange, biosimilar adoption, molecularly targeted therapy alignment, IV/SubQ formulation strategy, pathway adherence, and quality metrics. This role directly influences contract design, payer performance, and enterprise valuation through datadriven clinical strategy and crossfunctional leadership. The role supports and adheres to the US Oncology Compliance Program, including the Code of Ethics and Business Standards. Specific state laws may regulate that only licensed individuals perform compounding or mixing responsibilities; hence, certain incumbents may be prohibited from these tasks.

The essential duties and responsibilities (including but not limited to):

The Therapeutic Optimization Strategy

• Own and lead the enterprise strategy for oncology pharmacy clinical quality and therapeutic optimization.
• Establish clinical frameworks and governance for therapeutic optimization initiatives across disease states and therapy classes.
• Serve as senior clinical advisor to executive leadership on oncology pharmacy strategy, risk, and value tradeoffs.

Therapeutic Interchange (TIC) & Preferred Drug Strategy

• Lead enterprise therapeutic interchange and preferred drug strategies, including highimpact initiatives such as Imbruvica zanubrutinib, nivolumab to pembrolizumab where clinically appropriate.
• Ensure TIC strategies are evidence based, pathway aligned, and operationally executable across physician practices.
• Partner with Medical Leadership and Pathways Committees to secure approvals and oversee adoption.

Biosimilar & Payer Aligned Therapy Leadership

• Drive strategic pull through and related tools in collaboration with field teams and Managed Care leadership.
• Provide senior oversight and partnership to pharmacy clinical review team, ensuring alignment between field execution, clinical strategy, and payer performance.
• Own provider and site level tracking of guideline based therapy and preferred therapy adoption; ensure transparency, accountability, and corrective action where needed.

IV / Subcutaneous (SubQ) Formulation Strategy

• Lead enterprise IV SubQ optimization strategy, balancing clinical appropriateness, patient experience, operational efficiency, and financial performance.
• Ensure formulation strategy delivers performance to contract and supports throughput, site of care optimization, and payer alignment.
• Partner with nursing, infusion operations, and revenue cycle leaders to remove operational barriers and scale best practices.

Clinical Quality Metrics & Outcomes Accountability

• Define, implement, and own oncology pharmacy clinical quality metrics, including pathway adherence, therapeutic optimization rates, biosimilar utilization, molecular match rates, and formulation performance.
• Establish executive level dashboards and reporting cadences; translate data into action and strategic decision making.
• Lead continuous improvement initiatives to close performance gaps and elevate clinical quality across the enterprise.

Molecular Targeted Therapy Enablement

• Provide senior leadership for molecularly targeted therapy pull through, ensuring molecular results are effectively mapped to appropriate therapy selection.
• Partner with pathology, molecular diagnostics, informatics, and analytics to improve workflow integration and decision support.
• Improve valuation of PHI by enhancing data quality, structured capture, and compliant use of molecular and therapy data to support outcomes analysis and value-based strategies.

Standard of Care, Pathways & New Approvals

• Oversee evaluation and operationalization of new oncology approvals and evolving standards of care, such as:
  • CDK4/6 inhibitors in eligible populations (CY2026)
  • Enhertu and other high impact therapies (CY2026)
• Ensure timely pipeline updates, provider education, and utilization tracking.
• Drive the feedback loop: pathway updates utilization analytics insight generation more effective contract design.

Contract Design & Value Strategy

• Serve as clinical thought leader supporting oncology contract design, including preferred drug strategies, biosimilar economics, outcomes based considerations, and utilization guarantees.
• Partner with Managed Care team, Pharmacy Contracting, Finance, and Analytics to quantify value realization and inform future negotiations.
• Represent pharmacy clinical quality in manufacturer and payer discussions as a senior clinical authority.

• Lead complex, cross functional initiatives involving Pharmacy, Medical, Managed Care, Analytics, IT, Revenue Cycle, and Field Teams.
• Communicate strategy, progress, and risk to Pharmacy Executive Leadership with clarity and credibility.
• Establish governance, prioritization, and decision frameworks to ensure consistency and scalability across markets and sites.
• Provide critical insight into the future changes in pharmacy care to enable accurate fiscal forecasting.

The ideal candidate for the position will have the following background and experience:

• PharmD from an accredited school of pharmacy.
• Active, unrestricted pharmacist license.
• Minimum 8-10 years of progressive pharmacy experience, with significant focus in oncology.
• Demonstrated seniorlevel experience working with: Manufacturers, Payers / Managed Care, Physician practices and health systems
• Proven ability to translate clinical strategy into measurable operational, financial, and quality outcomes.
• Experience leading enterprisewide initiatives with executive visibility and accountability.

Preferred Qualifications:

• Board Certified Oncology Pharmacist (BCOP) strongly preferred.
• Deep experience with biosimilars, therapeutic interchange, oncology pathways, and molecularly targeted therapy.
• Familiarity with pullthrough / field enablement platforms.
• Experience supporting or influencing oncology contract negotiations and valuebased strategies.
• Advanced analytics literacy with provider and sitelevel performance measurement

Core Competencies

• Executive clinical leadership
• Oncology pharmacotherapy expertise
• Payer and manufacturer strategy
• Datadriven decision making
• Crossfunctional influence without direct authority
• Change leadership in complex clinical environments

Physical Demands:

The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions. Physical demands of this job typically require full range of body motion including manual and finger dexterity and eye-hand coordination and the ability to read and note appropriate measurements. Requires sitting/standing for extensive periods of time. Occasionally lifts and carries items weighing up to 40 lbs. Requires corrected vision and hearing to normal range.

Work Environment:

The work environment characteristics described here are representative of those an employee encounters while performing the essential functions of this job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions. While performing the duties of this job, the employee is regularly exposed to direct contact with patients with potential for exposure to toxic substances, medicinal preparations, and chemotherapeutic agents.